Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schrier, R. W.
Right arrow Articles by Caramelo, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schrier, R. W.
Right arrow Articles by Caramelo, C.

Journal of the American Society of Nephrology, Vol 4, 2-11, Copyright © 1993 by American Society of Nephrology

REVIEWS

Cellular action and interactions of arginine vasopressin in vascular smooth muscle: mechanisms and clinical implications

RW Schrier, V Briner and C Caramelo
Department of Medicine, University of Colorado School of Medicine, Denver 80262.

In recent years, much has been learned about the vascular action of arginine vasopressin (AVP) including (1) the structure, internalization, and recycling of the V1 AVP receptor; (2) the AVP postreceptor signaling events for the initial and sustained vascular smooth muscle cell contraction as well as the hormone's mitogenic effect; (3) the process of homologous and heterologous AVP desensitization in vascular smooth muscle cells; (4) the interaction of AVP with other vasoconstrictor and vasodilator hormones; (5) the vascular interaction of AVP with endothelial events; and (6) the vascular interactions that may occur with systemic acidemia or alkalemia as well as with ethanol. The various potential clinical and biochemical implications of these results are discussed briefly.


This article has been cited by other articles:


Home page
 J. Physiol.Home page
Y. Fujiwara, M. Hiroyama, A. Sanbe, T. Aoyagi, J.-i. Birumachi, J. Yamauchi, G. Tsujimoto, and A. Tanoue
Insulin hypersensitivity in mice lacking the V1b vasopressin receptor
J. Physiol., October 1, 2007; 584(1): 235 - 244.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
K. K. Henderson and K. L. Byron
Vasopressin-induced vasoconstriction: two concentration-dependent signaling pathways
J Appl Physiol, April 1, 2007; 102(4): 1402 - 1409.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
Y. Fujiwara, M. Hiroyama, A. Sanbe, J. Yamauchi, G. Tsujimoto, and A. Tanoue
Mutual regulation of vasopressin- and oxytocin-induced glucagon secretion in V1b vasopressin receptor knockout mice
J. Endocrinol., February 1, 2007; 192(2): 361 - 369.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
O. B. Vagnes, F. H. Hansen, J. J. Feng, B. M. Iversen, and W. J. Arendshorst
Enhanced Ca2+ response to AVP in preglomerular vessels from rats with genetic hypertension during different hydration states
Am J Physiol Renal Physiol, June 1, 2005; 288(6): F1249 - F1256.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
R. W. Fallet, H. Ikenaga, J. P. Bast, and P. K. Carmines
Relative contributions of Ca2+ mobilization and influx in renal arteriolar contractile responses to arginine vasopressin
Am J Physiol Renal Physiol, March 1, 2005; 288(3): F545 - F551.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
O. Vagnes, J. J. Feng, B. M. Iversen, and W. J. Arendshorst
Upregulation of V1 receptors in renal resistance vessels of rats developing genetic hypertension
Am J Physiol Renal Physiol, June 1, 2000; 278(6): F940 - F948.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
B. M. Iversen and W. J. Arendshorst
Exaggerated Ca2+ signaling in preglomerular arteriolar smooth muscle cells of genetically hypertensive rats
Am J Physiol Renal Physiol, February 1, 1999; 276(2): F260 - F270.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
B. M. Iversen and W. J. Arendshorst
ANG II and vasopressin stimulate calcium entry in dispersed smooth muscle cells of preglomerular arterioles
Am J Physiol Renal Physiol, March 1, 1998; 274(3): F498 - F508.
[Abstract] [Full Text] [PDF]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673